{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:49:24Z","timestamp":1789760964172,"version":"4.0.1"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170712"],"award-info":[{"award-number":["82170712"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.cellsig.2025.111952","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T11:55:28Z","timestamp":1750420528000},"page":"111952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Unraveling m6A RNA methylation: From epitranscriptomics to therapeutic frontiers in renal cell carcinoma"],"prefix":"10.1016","volume":"134","author":[{"given":"Tingfei","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolu","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunpeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0005","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12943-024-02095-8","article-title":"Programmed death receptor (PD-)1\/PD-ligand (L)1 in urological cancers\u202f: the \u201call-around warrior\u201d in immunotherapy","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"issue":"7","key":"10.1016\/j.cellsig.2025.111952_bb0010","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.molmed.2024.04.004","article-title":"Novel bladder-sparing approaches in patients with muscle-invasive bladder cancer","volume":"30","author":"Ben-David","year":"2024","journal-title":"Trends Mol. Med."},{"issue":"7","key":"10.1016\/j.cellsig.2025.111952_bb0015","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.ymthe.2020.04.023","article-title":"Single-cell transcriptome analysis reveals Intratumoral heterogeneity in ccRCC, which results in different clinical outcomes","volume":"28","author":"Hu","year":"2020","journal-title":"Mol. Ther."},{"issue":"7","key":"10.1016\/j.cellsig.2025.111952_bb0020","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/s41379-021-00779-w","article-title":"New developments in existing WHO entities and evolving molecular concepts: the genitourinary pathology society (GUPS) update on renal neoplasia","volume":"34","author":"Trpkov","year":"2021","journal-title":"Mod. Pathol."},{"issue":"12","key":"10.1016\/j.cellsig.2025.111952_bb0025","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/jama.2024.12848","article-title":"Renal cell carcinoma: a review","volume":"332","author":"Rose","year":"2024","journal-title":"Jama"},{"issue":"6","key":"10.1016\/j.cellsig.2025.111952_bb0030","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/jamaoncol.2024.0938","article-title":"Nivolumab+Ipilimumab as immunotherapeutic boost in metastatic urothelial carcinoma: a nonrandomized clinical trial","volume":"10","author":"Grimm","year":"2024","journal-title":"JAMA Oncol."},{"issue":"11","key":"10.1016\/j.cellsig.2025.111952_bb0035","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S1470-2045(23)00449-7","article-title":"Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as immunotherapeutic boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a multicentre, single-arm, phase 2 trial","volume":"24","author":"Grimm","year":"2023","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111952_bb0040","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S1470-2045(22)00128-0","article-title":"Nivolumab, nivolumab-ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial","volume":"23","author":"Vano","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.cellsig.2025.111952_bb0045","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"5","key":"10.1016\/j.cellsig.2025.111952_bb0050","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/annonc\/mdz056","article-title":"Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2020","volume":"30","author":"Escudier","year":"2019","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111952_bb0055","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.eururo.2020.09.027","article-title":"The Clinicopathologic and molecular landscape of clear cell papillary renal cell carcinoma: implications in diagnosis and management","volume":"79","author":"Weng","year":"2021","journal-title":"Eur. Urol."},{"issue":"6409","key":"10.1016\/j.cellsig.2025.111952_bb0060","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.aau1646","article-title":"RNA modifications modulate gene expression during development","volume":"361","author":"Frye","year":"2018","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.cellsig.2025.111952_bb0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41576-020-00295-8","article-title":"The epitranscriptome beyond m(6)A","volume":"22","author":"Wiener","year":"2021","journal-title":"Nat. Rev. Genet."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111952_bb0070","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.molcel.2023.01.006","article-title":"RNA m6A methylation across the transcriptome","volume":"83","author":"Sendinc","year":"2023","journal-title":"Mol. Cell"},{"issue":"6596","key":"10.1016\/j.cellsig.2025.111952_bb0075","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1126\/science.abe9582","article-title":"FTO mediates LINE1 m(6)A demethylation and chromatin regulation in mESCs and mouse development","volume":"376","author":"Wei","year":"2022","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.cellsig.2025.111952_bb0080","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/s41588-023-01452-5","article-title":"Crosstalk between RNA m(6)A and DNA methylation regulates transposable element chromatin activation and cell fate in human pluripotent stem cells","volume":"55","author":"Sun","year":"2023","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0085","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12943-023-01782-2","article-title":"The role of m6A methylation in therapy resistance in cancer","volume":"22","author":"Zhuang","year":"2023","journal-title":"Mol. Cancer"},{"issue":"10","key":"10.1016\/j.cellsig.2025.111952_bb0090","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1073\/pnas.71.10.3971","article-title":"Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells","volume":"71","author":"Desrosiers","year":"1974","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.cellsig.2025.111952_bb0095","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.tig.2012.11.003","article-title":"Reversible RNA adenosine methylation in biological regulation","volume":"29","author":"Jia","year":"2013","journal-title":"Trends Genet."},{"issue":"10","key":"10.1016\/j.cellsig.2025.111952_bb0100","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","article-title":"Reading, writing and erasing mRNA methylation","volume":"20","author":"Zaccara","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111952_bb0105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nchembio.1432","article-title":"A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation","volume":"10","author":"Liu","year":"2014","journal-title":"Nat. Chem. Biol."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111952_bb0110","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrg3724","article-title":"Gene expression regulation mediated through reversible m6A RNA methylation","volume":"15","author":"Fu","year":"2014","journal-title":"Nat. Rev. Genet."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0115","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12943-020-01204-7","article-title":"The potential role of RNA N6-methyladenosine in Cancer progression","volume":"19","author":"Wang","year":"2020","journal-title":"Mol. Cancer"},{"issue":"7","key":"10.1016\/j.cellsig.2025.111952_bb0120","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/cac2.12325","article-title":"Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma","volume":"42","author":"Zhang","year":"2022","journal-title":"Cancer Commun. (Lond.)"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0125","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12943-022-01705-7","article-title":"lncRNA ZNRD1-AS1 promotes malignant lung cell proliferation, migration, and angiogenesis via the miR-942\/TNS1 axis and is positively regulated by the m(6)a reader YTHDC2","volume":"21","author":"Wang","year":"2022","journal-title":"Mol. Cancer"},{"issue":"12","key":"10.1016\/j.cellsig.2025.111952_bb0130","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.ccell.2022.10.004","article-title":"The m(6)a reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia","volume":"40","author":"Weng","year":"2022","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.cellsig.2025.111952_bb0135","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1093\/nar\/gkaa048","article-title":"The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation","volume":"48","author":"Liu","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0140","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","article-title":"The role of m6A RNA methylation in cancer metabolism","volume":"21","author":"An","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0145","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12943-021-01362-2","article-title":"Comprehensive analyses of m6A regulators and interactive coding and non-coding RNAs across 32 cancer types","volume":"20","author":"Shen","year":"2021","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.cellsig.2025.111952_bb0150","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1002\/hep.29683","article-title":"RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2","volume":"67","author":"Chen","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cellsig.2025.111952_bb0155","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ccell.2017.02.013","article-title":"M(6)a demethylase ALKBH5 maintains Tumorigenicity of glioblastoma stem-like cells by sustaining FOXM1 expression and cell proliferation program","volume":"31","author":"Zhang","year":"2017","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.cellsig.2025.111952_bb0160","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1136\/gutjnl-2019-319639","article-title":"METTL3-mediated m(6)A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance","volume":"69","author":"Wang","year":"2020","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.cellsig.2025.111952_bb0165","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1158\/0008-5472.CAN-22-2485","article-title":"The m6A reader YTHDF2 promotes bladder cancer progression by suppressing RIG-I-mediated immune response","volume":"83","author":"Zhang","year":"2023","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0170","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41392-020-00453-8","article-title":"HIF-1\u03b1-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0175","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12943-019-1084-1","article-title":"Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N(6)-methyladenosine of Notch1","volume":"18","author":"Gu","year":"2019","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.cellsig.2025.111952_bb0180","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41571-023-00774-x","article-title":"The roles and implications of RNA m(6)A modification in cancer","volume":"20","author":"Deng","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.cellsig.2025.111952_bb0185","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1016\/j.drudis.2021.06.004","article-title":"m6A RNA methylation and beyond - the epigenetic machinery and potential treatment options","volume":"26","author":"Garbo","year":"2021","journal-title":"Drug Discov. Today"},{"issue":"7860","key":"10.1016\/j.cellsig.2025.111952_bb0190","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","article-title":"Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia","volume":"593","author":"Yankova","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0195","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41419-023-06411-w","article-title":"METTL3 facilitates renal cell carcinoma progression by PLOD2 m(6)A-methylation under prolonged hypoxia","volume":"15","author":"Chen","year":"2024","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0200","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12943-022-01549-1","article-title":"N(6)-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma","volume":"21","author":"Chen","year":"2022","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.cellsig.2025.111952_bb0205","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.7150\/thno.55424","article-title":"Downregulated METTL14 accumulates BPTF that reinforces super-enhancers and distal lung metastasis via glycolytic reprogramming in renal cell carcinoma","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.cellsig.2025.111952_bb0210","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/bju.15019","article-title":"The N(6) -methyladenosine (m(6) a) erasers alkylation repair homologue 5 (ALKBH5) and fat mass and obesity-associated protein (FTO) are prognostic biomarkers in patients with clear cell renal carcinoma","volume":"125","author":"Strick","year":"2020","journal-title":"BJU Int."},{"issue":"7608","key":"10.1016\/j.cellsig.2025.111952_bb0215","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nature18298","article-title":"Structural basis of N(6)-adenosine methylation by the METTL3-METTL14 complex","volume":"534","author":"Wang","year":"2016","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.cellsig.2025.111952_bb0220","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/cr.2017.117","article-title":"Mettl3\u2212\/Mettl14-mediated mRNA N(6)-methyladenosine modulates murine spermatogenesis","volume":"27","author":"Lin","year":"2017","journal-title":"Cell Res."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111952_bb0225","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neuron.2018.06.007","article-title":"Mettl14 is essential for epitranscriptomic regulation of striatal function and learning","volume":"99","author":"Koranda","year":"2018","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0230","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12943-019-1053-8","article-title":"WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1","volume":"18","author":"Chen","year":"2019","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0235","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13046-021-01871-4","article-title":"RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent","volume":"40","author":"Wang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2025.111952_bb0240","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41421-018-0019-0","article-title":"VIRMA mediates preferential m(6)A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation","volume":"4","author":"Yue","year":"2018","journal-title":"Cell Discov"},{"issue":"6","key":"10.1016\/j.cellsig.2025.111952_bb0245","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.molcel.2018.02.015","article-title":"Zc3h13 regulates nuclear RNA m(6)A methylation and mouse embryonic stem cell self-renewal","volume":"69","author":"Wen","year":"2018","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.cellsig.2025.111952_bb0250","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/nar\/gkz1147","article-title":"The human methyltransferase ZCCHC4 catalyses N6-methyladenosine modification of 28S ribosomal RNA","volume":"48","author":"Pinto","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"10.1016\/j.cellsig.2025.111952_bb0255","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nchembio.687","article-title":"N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO","volume":"7","author":"Jia","year":"2011","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0260","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41420-022-01151-w","article-title":"FTO promotes clear cell renal cell carcinoma progression via upregulation of PDK1 through an m(6)A dependent pathway","volume":"8","author":"Shen","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0265","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.molcel.2012.10.015","article-title":"ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility","volume":"49","author":"Zheng","year":"2013","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0270","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","article-title":"FTO plays an oncogenic role in acute myeloid leukemia as a N(6)-Methyladenosine RNA demethylase","volume":"31","author":"Li","year":"2017","journal-title":"Cancer Cell"},{"issue":"613","key":"10.1016\/j.cellsig.2025.111952_bb0275","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf6045","article-title":"Aberrant activation of m6A demethylase FTO renders HIF2\u03b1(low\/\u2212) clear cell renal cell carcinoma sensitive to BRD9 inhibitors","volume":"13","author":"Zhang","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111952_bb0280","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1111\/jcmm.14128","article-title":"N6-methyladenosine demethylase FTO suppresses clear cell renal cell carcinoma through a novel FTO-PGC-1\u03b1 signalling axis","volume":"23","author":"Zhuang","year":"2019","journal-title":"J. Cell. Mol. Med."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111952_bb0285","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","article-title":"N(6)-methyladenosine modulates messenger RNA translation efficiency","volume":"161","author":"Wang","year":"2015","journal-title":"Cell"},{"issue":"7481","key":"10.1016\/j.cellsig.2025.111952_bb0290","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature12730","article-title":"N6-methyladenosine-dependent regulation of messenger RNA stability","volume":"505","author":"Wang","year":"2014","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.cellsig.2025.111952_bb0295","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210279","article-title":"The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity","volume":"218","author":"Ma","year":"2021","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0300","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12943-023-01912-w","article-title":"CircPPAP2B controls metastasis of clear cell renal cell carcinoma via HNRNPC-dependent alternative splicing and targeting the miR-182-5p\/CYP1B1 axis","volume":"23","author":"Zheng","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0305","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12943-023-01771-5","article-title":"CircZBTB44 promotes renal carcinoma progression by stabilizing HK3 mRNA structure","volume":"22","author":"Li","year":"2023","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.cellsig.2025.111952_bb0310","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s41419-021-04038-3","article-title":"EGR2-mediated regulation of m(6)A reader IGF2BP proteins drive RCC tumorigenesis and metastasis via enhancing S1PR3 mRNA stabilization","volume":"12","author":"Ying","year":"2021","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.cellsig.2025.111952_bb0315","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1021\/acscentsci.2c00107","article-title":"Allosteric regulation of IGF2BP1 as a novel strategy for the activation of tumor immune microenvironment","volume":"8","author":"Liu","year":"2022","journal-title":"ACS Cent. Sci."},{"issue":"23","key":"10.1016\/j.cellsig.2025.111952_bb0320","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1158\/0008-5472.CAN-22-1289","article-title":"MNX1-AS1 promotes phase separation of IGF2BP1 to drive c-Myc-mediated cell-cycle progression and proliferation in lung Cancer","volume":"82","author":"Zhu","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2025.111952_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101003","article-title":"CircPTEN suppresses human clear cell renal carcinoma progression and resistance to mTOR inhibitors by targeting epigenetic modification","volume":"71","author":"Zhan","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.cellsig.2025.111952_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101518","article-title":"The controversial role and therapeutic development of the m6A demethylase FTO in renal cell carcinoma","volume":"25","author":"Zhang","year":"2022","journal-title":"Transl. Oncol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111952_bb0335","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/cas.15212","article-title":"Methyltransferase-like 14 suppresses growth and metastasis of renal cell carcinoma by decreasing long noncoding RNA NEAT1","volume":"113","author":"Liu","year":"2022","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0340","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13046-018-0706-6","article-title":"Wilms\u2019 tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stability","volume":"37","author":"Tang","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.cellsig.2025.111952_bb0345","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1089\/dna.2020.5767","article-title":"Expression profile analysis of m6A RNA methylation regulators indicates they are immune signature associated and can predict survival in kidney renal cell carcinoma","volume":"39","author":"Fang","year":"2020","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.cellsig.2025.111952_bb0350","article-title":"N6-Methyladenosine writer gene ZC3H13 predicts immune phenotype and therapeutic opportunities in kidney renal clear cell carcinoma","volume":"11","author":"Guo","year":"2021","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111952_bb0355","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/mc.23297","article-title":"N(6) -Methyladenosine (m(6)a) readers are dysregulated in renal cell carcinoma","volume":"60","author":"von Hagen","year":"2021","journal-title":"Mol. Carcinog."},{"issue":"12","key":"10.1016\/j.cellsig.2025.111952_bb0360","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1512","article-title":"circRARS synergises with IGF2BP3 to regulate RNA methylation recognition to promote tumour progression in renal cell carcinoma","volume":"13","author":"Liu","year":"2023","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0365","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12967-022-03496-3","article-title":"The methyltransferase METTL3 promotes tumorigenesis via mediating HHLA2 mRNA m6A modification in human renal cell carcinoma","volume":"20","author":"Zhu","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cellsig.2025.111952_bb0370","article-title":"m(6)A-mRNA methylation regulates gene expression and programmable m(6)a modification of cellular RNAs with CRISPR-Cas13b in renal cell carcinoma","volume":"12","author":"Gan","year":"2021","journal-title":"Front. Genet."},{"issue":"11","key":"10.1016\/j.cellsig.2025.111952_bb0375","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/s41419-023-06298-7","article-title":"Hypoxia-induced PLOD2 promotes clear cell renal cell carcinoma progression via modulating EGFR-dependent AKT pathway activation","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111952_bb0380","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.906","article-title":"ZNF677 suppresses renal cell carcinoma progression through N6-methyladenosine and transcriptional repression of CDKN3","volume":"12","author":"Li","year":"2022","journal-title":"Clin. Transl. Med."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111952_bb0385","first-page":"611","article-title":"Downregulation of the FTO m(6)A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to Wnt inhibitors","volume":"2","author":"Jeschke","year":"2021","journal-title":"Nat. Can."},{"key":"10.1016\/j.cellsig.2025.111952_bb0390","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.omtn.2021.12.024","article-title":"METTL14-mediated Lnc-LSG1 m6A modification inhibits clear cell renal cell carcinoma metastasis via regulating ESRP2 ubiquitination","volume":"27","author":"Shen","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0395","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12964-022-00831-5","article-title":"METTL14-mediated N(6)-methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma","volume":"20","author":"Liu","year":"2022","journal-title":"Cell Commun. Signal."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111952_bb0400","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1158\/0008-5472.CAN-20-1619","article-title":"DMDRMR-mediated regulation of m(6)A-modified CDK4 by m(6)a reader IGF2BP3 drives ccRCC progression","volume":"81","author":"Gu","year":"2021","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0405","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12943-022-01497-w","article-title":"CircMET promotes tumor proliferation by enhancing CDKN2A mRNA decay and upregulating SMAD3","volume":"21","author":"Yang","year":"2022","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.cellsig.2025.111952_bb0410","doi-asserted-by":"crossref","first-page":"617","DOI":"10.7150\/ijbs.29689","article-title":"Activation of AMPK by metformin promotes renal cancer cell proliferation under glucose deprivation through its interaction with PKM2","volume":"15","author":"Liu","year":"2019","journal-title":"Int. J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111952_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygeno.2022.110424","article-title":"SHMT2 promotes the tumorigenesis of renal cell carcinoma by regulating the m6A modification of PPAT","volume":"114","author":"Huo","year":"2022","journal-title":"Genomics"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0420","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13045-021-01059-5","article-title":"Low expression of TRAF3IP2-AS1 promotes progression of NONO-TFE3 translocation renal cell carcinoma by stimulating N(6)-methyladenosine of PARP1 mRNA and downregulating PTEN","volume":"14","author":"Yang","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111952_bb0425","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ccell.2021.02.015","article-title":"Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma","volume":"39","author":"Bi","year":"2021","journal-title":"Cancer Cell"},{"issue":"24","key":"10.1016\/j.cellsig.2025.111952_bb0430","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2103240118","article-title":"Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0435","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12943-023-01841-8","article-title":"m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism","volume":"22","author":"Yue","year":"2023","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.cellsig.2025.111952_bb0440","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.cmet.2024.01.018","article-title":"Methionine secreted by tumor-associated pericytes supports cancer stem cells in clear cell renal carcinoma","volume":"36","author":"Zhang","year":"2024","journal-title":"Cell Metab."},{"issue":"36","key":"10.1016\/j.cellsig.2025.111952_bb0445","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2018.79.2648","article-title":"The Immunobiology of kidney cancer","volume":"36","author":"Drake","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111952_bb0450","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/s41591-024-02978-9","article-title":"A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma","volume":"30","author":"Kinget","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellsig.2025.111952_bb0455","article-title":"METTL14 acts as a potential regulator of tumor immune and progression in clear cell renal cell carcinoma","volume":"12","author":"Xu","year":"2021","journal-title":"Front. Genet."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111952_bb0460","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001646","article-title":"m(6)A modification patterns and tumor immune landscape in clear cell renal carcinoma","volume":"9","author":"Zhong","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.cellsig.2025.111952_bb0465","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12935-020-01238-3","article-title":"Identification of a m(6)A RNA methylation regulators-based signature for predicting the prognosis of clear cell renal carcinoma","volume":"20","author":"Chen","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0470","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","article-title":"The role of m6A modification in the biological functions and diseases","volume":"6","author":"Jiang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"10","key":"10.1016\/j.cellsig.2025.111952_bb0475","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3390\/jpm11100996","article-title":"Deregulation of N6-Methyladenosine RNA modification and its erasers FTO\/ALKBH5 among the Main renal cell tumor subtypes","volume":"11","author":"Guimar\u00e3es-Teixeira","year":"2021","journal-title":"J. Pers. Med."},{"issue":"7","key":"10.1016\/j.cellsig.2025.111952_bb0480","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13986","article-title":"ALKBH1 contributes to renal cell carcinoma progression by reducing N6-methyladenine of GPR137","volume":"53","author":"Li","year":"2023","journal-title":"Eur. J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0485","article-title":"Predicting response of immunotherapy and targeted therapy and prognosis characteristics for renal clear cell carcinoma based on m1A methylation regulators","volume":"13","author":"Li","year":"2023","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111952_bb0490","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3892\/or.2015.4017","article-title":"Clinical significance and therapeutic potential of prostate cancer antigen-1\/ALKBH3 in human renal cell carcinoma","volume":"34","author":"Hotta","year":"2015","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0495","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/jcp.29871","article-title":"LINC01426 contributes to clear cell renal cell carcinoma progression by modulating CTBP1\/miR-423-5p\/FOXM1 axis via interacting with IGF2BP1","volume":"236","author":"Jiang","year":"2021","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111952_bb0500","article-title":"Comprehensive proteogenomic characterization of rare kidney tumors","volume":"5","author":"Li","year":"2024","journal-title":"Cell Rep Med"},{"issue":"2","key":"10.1016\/j.cellsig.2025.111952_bb0505","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41419-021-03489-y","article-title":"LncRNA CDKN2B-AS1 stabilized by IGF2BP3 drives the malignancy of renal clear cell carcinoma through epigenetically activating NUF2 transcription","volume":"12","author":"Xie","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2025.111952_bb0510","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.709548","article-title":"YTHDF2 is a potential biomarker and associated with immune infiltration in kidney renal clear cell carcinoma","volume":"12","author":"Su","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cellsig.2025.111952_bb0515","article-title":"m(6)A RNA methylation regulators impact prognosis and tumor microenvironment in renal papillary cell carcinoma","volume":"11","author":"Chen","year":"2021","journal-title":"Front. Oncol."},{"issue":"21","key":"10.1016\/j.cellsig.2025.111952_bb0520","doi-asserted-by":"crossref","first-page":"22078","DOI":"10.18632\/aging.104053","article-title":"Prognostic risk signature based on the expression of three m6A RNA methylation regulatory genes in kidney renal papillary cell carcinoma","volume":"12","author":"Sun","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"10","key":"10.1016\/j.cellsig.2025.111952_bb0525","doi-asserted-by":"crossref","first-page":"8807","DOI":"10.3390\/ijms24108807","article-title":"Supervised learning and multi-omics integration reveals clinical significance of inner membrane mitochondrial protein (IMMT) in prognostic prediction, tumor immune microenvironment and precision medicine for kidney renal clear cell carcinoma","volume":"24","author":"Chen","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2025.111952_bb0530","article-title":"Comprehensive evaluation of the m(6)a regulator prognostic risk score in the prediction of immunotherapy response in clear cell renal cell carcinoma","volume":"13","author":"Yu","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111952_bb0535","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/cac2.12413","article-title":"N6-methyladenosine-modified DBT alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2\/YAP axis-regulated hippo pathway","volume":"43","author":"Miao","year":"2023","journal-title":"Cancer Commun. (Lond.)"},{"issue":"3","key":"10.1016\/j.cellsig.2025.111952_bb0540","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.molcel.2016.03.021","article-title":"The m(6)A methyltransferase METTL3 promotes translation in human cancer cells","volume":"62","author":"Lin","year":"2016","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0545","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13046-021-01880-3","article-title":"METTL3-mediated m(6)A mRNA modification of FBXW7 suppresses lung adenocarcinoma","volume":"40","author":"Wu","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"640","key":"10.1016\/j.cellsig.2025.111952_bb0550","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abk2709","article-title":"Inhibition of METTL3 attenuates renal injury and inflammation by alleviating TAB3 m6A modifications via IGF2BP2-dependent mechanisms","volume":"14","author":"Wang","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"7728","key":"10.1016\/j.cellsig.2025.111952_bb0555","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41586-018-0615-z","article-title":"LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration","volume":"562","author":"Deng","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0560","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ccell.2020.04.017","article-title":"Targeting FTO suppresses cancer stem cell maintenance and immune evasion","volume":"38","author":"Su","year":"2020","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.cellsig.2025.111952_bb0565","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","article-title":"Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation","volume":"20","author":"Huang","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cellsig.2025.111952_bb0570","article-title":"m(6)A regulator-mediated methylation modification model predicts prognosis, tumor microenvironment characterizations and response to immunotherapies of clear cell renal cell carcinoma","volume":"11","author":"Xu","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0575","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12943-022-01510-2","article-title":"m6A modification: recent advances, anticancer targeted drug discovery and beyond","volume":"21","author":"Deng","year":"2022","journal-title":"Mol. Cancer"},{"issue":"17","key":"10.1016\/j.cellsig.2025.111952_bb0580","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1016\/j.molcel.2023.08.010","article-title":"Single-nucleus multiomic mapping of m(6)A methylomes and transcriptomes in native populations of cells with sn-m6A-CT","volume":"83","author":"Hamashima","year":"2023","journal-title":"Mol. Cell."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111952_bb0585","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41587-023-01831-7","article-title":"Single-cell m(6)A mapping in vivo using picoMeRIP-seq","volume":"42","author":"Li","year":"2024","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0590","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12943-024-02062-3","article-title":"Single-cell tumor heterogeneity landscape of hepatocellular carcinoma: unraveling the pro-metastatic subtype and its interaction loop with fibroblasts","volume":"23","author":"Guo","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0595","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12943-023-01913-9","article-title":"Unveiling the hidden AP-1: revealing the crucial role of AP-1 in ccRCC at single-cell resolution","volume":"22","author":"Zheng","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cellsig.2025.111952_bb0600","article-title":"Mitophagy and clear cell renal cell carcinoma: insights from single-cell and spatial transcriptomics analysis","volume":"15","author":"Jiang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2025.111952_bb0605","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1427475","article-title":"Anoikis resistance regulates immune infiltration and drug sensitivity in clear-cell renal cell carcinoma: insights from multi omics, single cell analysis and in vitro experiment","volume":"15","author":"Wen","year":"2024","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.cellsig.2025.111952_bb0610","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1093\/nar\/gkae169","article-title":"Determinant of m6A regional preference by transcriptional dynamics","volume":"52","author":"Wang","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"15","key":"10.1016\/j.cellsig.2025.111952_bb0615","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1016\/j.molcel.2023.06.021","article-title":"mRNA stability and m(6)A are major determinants of subcellular mRNA localization in neurons","volume":"83","author":"Loedige","year":"2023","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111952_bb0620","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12943-022-01522-y","article-title":"Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification","volume":"21","author":"Hu","year":"2022","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.cellsig.2025.111952_bb0625","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1136\/gutjnl-2022-328845","article-title":"Targeting m(6)A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer","volume":"72","author":"Bao","year":"2023","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.cellsig.2025.111952_bb0630","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/s41587-021-00949-w","article-title":"Identification of differential RNA modifications from nanopore direct RNA sequencing with xPore","volume":"39","author":"Pratanwanich","year":"2021","journal-title":"Nat. Biotechnol."},{"issue":"9","key":"10.1016\/j.cellsig.2025.111952_bb0635","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s41588-020-0644-z","article-title":"Genetic analyses support the contribution of mRNA N(6)-methyladenosine (m(6)A) modification to human disease heritability","volume":"52","author":"Zhang","year":"2020","journal-title":"Nat. Genet."},{"issue":"10","key":"10.1016\/j.cellsig.2025.111952_bb0640","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1038\/s41380-024-02574-w","article-title":"Integration of multi-omics summary data reveals the role of N6-methyladenosine in neuropsychiatric disorders","volume":"29","author":"Liufu","year":"2024","journal-title":"Mol. Psychiatry"},{"issue":"D1","key":"10.1016\/j.cellsig.2025.111952_bb0645","doi-asserted-by":"crossref","first-page":"D1179","DOI":"10.1093\/nar\/gkac821","article-title":"TWAS atlas: a curated knowledgebase of transcriptome-wide association studies","volume":"51","author":"Lu","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"21","key":"10.1016\/j.cellsig.2025.111952_bb0650","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1021\/acs.accounts.3c00451","article-title":"Chemical inhibitors targeting the oncogenic m(6)A modifying proteins","volume":"56","author":"Huang","year":"2023","journal-title":"Acc. Chem. Res."},{"issue":"12","key":"10.1016\/j.cellsig.2025.111952_bb0655","doi-asserted-by":"crossref","first-page":"8216","DOI":"10.1021\/jacs.3c12726","article-title":"Single-atom catalysts mediated bioorthogonal modulation of N(6)-Methyladenosine methylation for boosting cancer immunotherapy","volume":"146","author":"Sun","year":"2024","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111952_bb0660","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41588-024-01662-5","article-title":"Multi-omic profiling of clear cell renal cell carcinoma identifies metabolic reprogramming associated with disease progression","volume":"56","author":"Hu","year":"2024","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111952_bb0665","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004206","article-title":"Single-cell transcriptomics reveals a low CD8(+) T cell infiltrating state mediated by fibroblasts in recurrent renal cell carcinoma","volume":"10","author":"Peng","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.cellsig.2025.111952_bb0670","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008226","article-title":"Targeting oxidative phosphorylation to increase the efficacy of immune-combination therapy in renal cell carcinoma","volume":"12","author":"Tian","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.cellsig.2025.111952_bb0675","article-title":"Regulatory effects of natural products on N6-methyladenosine modification: a novel therapeutic strategy for cancer","volume":"29","author":"Mao","year":"2024","journal-title":"Drug Discov. Today"},{"issue":"8","key":"10.1016\/j.cellsig.2025.111952_bb0680","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41585-023-00851-x","article-title":"RNA N(6)-methyladenosine modifications in urological cancers: from mechanism to application","volume":"21","author":"Yang","year":"2024","journal-title":"Nat. Rev. Urol."},{"issue":"9","key":"10.1016\/j.cellsig.2025.111952_bb0685","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.1093\/nar\/gkae280","article-title":"m6ACali: machine learning-powered calibration for accurate m6A detection in MeRIP-Seq","volume":"52","author":"Ye","year":"2024","journal-title":"Nucleic Acids Res."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825003675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825003675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T04:26:53Z","timestamp":1762316813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656825003675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":137,"alternative-id":["S0898656825003675"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.111952","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unraveling m6A RNA methylation: From epitranscriptomics to therapeutic frontiers in renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.111952","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111952"}}